EXHIBIT 99.1


                                                               [GRAPHIC OMITTED]

                         MIM Closes Vitality Acquisition



         ELMSFORD, NY - January 31, 2002 - MIM Corporation (NASDAQ: MIMS)
(CBOE:OQX), a pharmaceutical healthcare organization, today announced that it
has completed its acquisition of Vitality Pharmaceutical Services, a national
specialty pharmaceutical provider based in Roslyn Heights, New York.

         "We are pleased to have closed the acquisition so swiftly," stated MIM
Chairman and Chief Executive Officer, Richard H. Friedman. "Vitality is expected
to be immediately accretive and our specialty team is eager to continue the
integration process. The acquisition brings our specialty lives to approximately
11,700 and we look forward to further growth."

         MIM has acquired all of the stock of Vitality for $45 million, $35
million in cash and $10 million in MIM common stock (based on a trailing 20-day
average). The MIM common stock issued to the Vitality stockholders is not
registered under the Securities Act of 1933 and may not be offered or sold in
the United States absent registration or an applicable exemption from
registration requirements.

MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare
organization delivering innovative pharmacy benefit and healthcare solutions
that provide results beyond expectations. We excel by harnessing our clinical
expertise, sophisticated data management, and therapeutic fulfillment
capability, and combine it with our dedicated, responsive team of professionals
that understands our partners' needs. The result is cost-effective solutions
enhancing the quality of patient life.

This press release may contain statements which constitute forward looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the intent, belief or current expectations
of the Company, its directors, or its officers with respect to the future
operating performance of the Company. Investors are cautioned that any such
forward looking statements are not guarantees of future performance and involve
risks and uncertainties, and that actual results may differ materially from
those in the forward looking statements as a result of various factors.
Important factors that could cause such differences are described in the
Company's periodic filings with the Securities and Exchange Commission.

Contacts:

Barry A. Posner                                Rachel Levine
Executive Vice President                       Investor Relations
MIM Corporation                                The Anne McBride Co.
914-460-1638                                   212-983-1702
Email: investor_relations@mimcorporation.com   Email: rlevine@annemcbride.com